Trials / Completed
CompletedNCT03292965
Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery
Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery: Comparison of Neostigmine and Sugammadex
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring
Detailed description
At the end of surgery, decide the dosage of reversal referring to quantitative neuromuscular monitoring value (TOF). After the administration of reversal, the anesthesiologist who are going to manage the participant should not check the quantitative neuromuscular monitoring and determine the timing of extubation only with his (or her) judgement. After entering post-anaesthesia care unit (PACU) measure the TOF value and check the incidence of TOF ratio \> 0.9 between the neostigmine group and sugammadex group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neostigmine | Referring to the randomisation allocation program, participants allocated to group neostigmine, administrate neostigmine as reversal |
| DRUG | Sugammadex | Referring to the randomisation allocation program, participants allocated to group sugammadex, administrate sugammadex as reversal |
Timeline
- Start date
- 2017-09-28
- Primary completion
- 2017-11-29
- Completion
- 2017-11-29
- First posted
- 2017-09-26
- Last updated
- 2018-10-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03292965. Inclusion in this directory is not an endorsement.